Schorno Dean L: insider trades.
Schorno Dean L reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Schorno Dean L
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Rigel Pharmaceuticals Inc (RIGL) | Officer · EVP & Chief Financial Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Rigel Pharmaceuticals Inc | M | 694 | $12.7 | 79,056 | Form 4 |
| 2026-09-02 | Rigel Pharmaceuticals Inc | M | 1,286 | $24.2 | 82,962 | Form 4 |
| 2026-09-02 | Rigel Pharmaceuticals Inc | M | 2,000 | $24.2 | 81,676 | Form 4 |
| 2026-09-02 | Rigel Pharmaceuticals Inc | M | 620 | $18.7 | 79,676 | Form 4 |
| 2026-09-01 | Rigel Pharmaceuticals Inc | F | 928 | $47.5 | 78,362 | Form 4 |
Questions
What stock did Schorno Dean L buy or sell?
Schorno Dean L reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Schorno Dean L the same person as other filers with this name?
This page covers SEC CIK 1509688 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/schorno-dean-l-1509688.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.